je.st
news
Merck to buy Idenix Pharma for $3.85 billion
2014-06-09 15:33:35| Biotech - Topix.net
Merck & Co. says the Cambridge, Massachusetts, company has built a promising portfolio of hepatitis C treatments, including three in clinical testing Merck will spend $24.50 per share in cash for each share, which closed at $7.23 Friday.
Tags: buy
billion
pharma
merck
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||